Plasma-Lyte 148 (pH 7.4) SODIUM CHLORIDE SODIUM GLUCONATE SODIUM ACETATE POTASSIUM CHLORIDE MAGNESIUM CHLORIDE BAXTER HEALTHCARE CORPORATION FDA Approved No description available yet.
FunFoxMeds bottle
Substance Magnesium Chloride
Route
INTRAVENOUS

Drug Facts

Composition & Profile

Quantities
1000 ml 100 ml

Identifiers & Packaging

Container Type BOTTLE
UNII
02F3473H9O 660YQ98I10 4550K0SC9B 451W47IQ8X R6Q3791S76
Packaging

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL Container Label Baxter Viaflo GCCE0324 1000 mL 100 200 300 400 500 600 700 800 900 Plasma-Lyte 148 (pH 7.4) Solution for Infusion pH 6.5 – 8.0 Isotonic Osmolarity 295 m0sm/l (approx) Formula per 1000ml Sodium Chloride 5.26 g Potassium Chloride 0.37 g Magnesium Chloride hexahydrate 0.30 g Sodium Acetate trihydrate 3.68 g Sodium Gluconate 5.02 g Water for Injections Sodium Hydroxide mmol per 100 mL (approx) Sodium 140 Chloride 98 Potassium 5 Acetate 27 Magnesium 1.5 Gluconate 23 IV administration Read package leaflet before use Keep out of the sight and reach of children Do not remove from overwrap until ready for use Do not use unless solution is clear without visible particles and container undamaged Do not reconnect partially used bags Store below 30 o C POM 07 0 UN-35-03-560 1 Marketing Authorization Holder: Baxter Healthcare Ltd. Caxton Way Thetford Norfolk IP 24 3SE United Kingdom Manufacturer: Bieffe Medital S.A. Ctra de Biescas-Senegüé 22666 Sabiñánigo (Huesca) Spain LOT EXP PlasmaLyte 1000ml Representative Container Label.jpg

Package Descriptions
  • PACKAGE/LABEL PRINCIPAL DISPLAY PANEL Container Label Baxter Viaflo GCCE0324 1000 mL 100 200 300 400 500 600 700 800 900 Plasma-Lyte 148 (pH 7.4) Solution for Infusion pH 6.5 – 8.0 Isotonic Osmolarity 295 m0sm/l (approx) Formula per 1000ml Sodium Chloride 5.26 g Potassium Chloride 0.37 g Magnesium Chloride hexahydrate 0.30 g Sodium Acetate trihydrate 3.68 g Sodium Gluconate 5.02 g Water for Injections Sodium Hydroxide mmol per 100 mL (approx) Sodium 140 Chloride 98 Potassium 5 Acetate 27 Magnesium 1.5 Gluconate 23 IV administration Read package leaflet before use Keep out of the sight and reach of children Do not remove from overwrap until ready for use Do not use unless solution is clear without visible particles and container undamaged Do not reconnect partially used bags Store below 30 o C POM 07 0 UN-35-03-560 1 Marketing Authorization Holder: Baxter Healthcare Ltd. Caxton Way Thetford Norfolk IP 24 3SE United Kingdom Manufacturer: Bieffe Medital S.A. Ctra de Biescas-Senegüé 22666 Sabiñánigo (Huesca) Spain LOT EXP PlasmaLyte 1000ml Representative Container Label.jpg